Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of a Potent, CNS‐Penetrant Orexin Receptor Antagonist Based on an N,N‐Disubstituted‐1,4‐diazepane Scaffold that Promotes Sleep in Rats
David B. Whitman, Christopher D. Cox, Michael J. Breslin, et al.
ChemMedChem (2009) Vol. 4, Iss. 7, pp. 1069-1074
Closed Access | Times Cited: 70

Showing 26-50 of 70 citing articles:

Structure–Activity Relationship, Biological, and Pharmacological Characterization of the Proline Sulfonamide ACT‐462206: a Potent, Brain‐Penetrant Dual Orexin 1/Orexin 2 Receptor Antagonist
Christoph Boss, Catherine Roch‐Brisbare, Michel A. Steiner, et al.
ChemMedChem (2014) Vol. 9, Iss. 11, pp. 2486-2496
Closed Access | Times Cited: 38
Novel Octahydropyrrolo[3,4-c]pyrroles Are Selective Orexin-2 Antagonists: SAR Leading to a Clinical Candidate
Michael A. Letavic, Pascal Bonaventure, Nicholas I. Carruthers, et al.
Journal of Medicinal Chemistry (2015) Vol. 58, Iss. 14, pp. 5620-5636
Closed Access | Times Cited: 38
The hypocretin/orexin antagonist almorexant promotes sleep without impairment of performance in rats
Stephen R. Morairty, Alan J. Wilk, Webster U. Lincoln, et al.
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 37
Synthesis of 2-aminobenzoxazoles via copper-catalyzed electrophilic amination of benzoxazoles with O-benzoyl hydroxylamines
Sirilata Yotphan, Danupat Beukeaw, Vichai Reutrakul
Tetrahedron (2013) Vol. 69, Iss. 32, pp. 6627-6633
Closed Access | Times Cited: 37
The role of orexins/hypocretins in alcohol use and abuse: an appetitive-reward relationship
Andrezza K. Kim, Robyn M. Brown, Andrew J. Lawrence
Frontiers in Behavioral Neuroscience (2012) Vol. 6
Open Access | Times Cited: 33
Mechanisms underlying obesity resistance associated with high spontaneous physical activity
Jennifer A. Teske, Charles J. Billington, Catherine M. Kotz
Neuroscience (2013) Vol. 256, pp. 91-100
Open Access | Times Cited: 33
Synthesis of 2-Aminobenzoxazoles Using Tetramethyl Orthocarbonate or 1,1-Dichlorodiphenoxymethane
Christopher L. Cioffi, John J. Lansing, Hamza Yüksel
The Journal of Organic Chemistry (2010) Vol. 75, Iss. 22, pp. 7942-7945
Closed Access | Times Cited: 35
Intracerebroventricular injection of orexin-2 receptor antagonist promotes REM sleep
Basheer Ahamad Kummangal, Deependra Kumar, Hruda Nanda Mallick
Behavioural Brain Research (2012) Vol. 237, pp. 59-62
Closed Access | Times Cited: 30
Discovery of 3,9-diazabicyclo[4.2.1]nonanes as potent dual orexin receptor antagonists with sleep-promoting activity in the rat
Paul J. Coleman, John D. Schreier, Anthony J. Roecker, et al.
Bioorganic & Medicinal Chemistry Letters (2010) Vol. 20, Iss. 14, pp. 4201-4205
Closed Access | Times Cited: 27
Solvent-Free or Low-Solvent Large-Scale Preparation of Chloropyrimidine and Analogues
Zhihua Sun, Han Wang, Kun Wen, et al.
The Journal of Organic Chemistry (2011) Vol. 76, Iss. 10, pp. 4149-4153
Closed Access | Times Cited: 27
Radiosynthesis and evaluation of [11C]EMPA as a potential PET tracer for orexin 2 receptors
Changning Wang, Christian K. Moseley, Stephen M. Carlin, et al.
Bioorganic & Medicinal Chemistry Letters (2013) Vol. 23, Iss. 11, pp. 3389-3392
Open Access | Times Cited: 25
Evaluation of potential PET imaging probes for the orexin 2 receptors
Changning Wang, Colin M. Wilson, Christian K. Moseley, et al.
Nuclear Medicine and Biology (2013) Vol. 40, Iss. 8, pp. 1000-1005
Open Access | Times Cited: 24
A Cu2O/TBAB-promoted approach to synthesize heteroaromatic 2-amines via one-pot cyclization of aryl isothiocyanates with ortho-substituted amines in water
Jinli Zhang, Ling Chen, Yibo Dong, et al.
Organic & Biomolecular Chemistry (2020) Vol. 18, Iss. 37, pp. 7425-7430
Closed Access | Times Cited: 18
Discovery of Highly Potent Dual Orexin Receptor Antagonists via a Scaffold‐Hopping Approach
Bibia Heidmann, John Gatfield, Catherine Roch, et al.
ChemMedChem (2016) Vol. 11, Iss. 19, pp. 2132-2146
Closed Access | Times Cited: 17
Discovery of diazepane amide DORAs and 2-SORAs enabled by exploration of isosteric quinazoline replacements
Anthony J. Roecker, Swati P. Mercer, Jeffrey M. Bergman, et al.
Bioorganic & Medicinal Chemistry Letters (2015) Vol. 25, Iss. 21, pp. 4992-4999
Closed Access | Times Cited: 16
Discovery, Synthesis, and Evaluation of 2,4-Diaminoquinazolines as a Novel Class of Pancreatic β-Cell-Protective Agents against Endoplasmic Reticulum (ER) Stress
Hongliang Duan, Jae Wook Lee, Sung Won Moon, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 17, pp. 7783-7800
Open Access | Times Cited: 16
A New Positron Emission Tomography Probe for Orexin Receptors Neuroimaging
Ping Bai, Sha Bai, Michael S. Placzek, et al.
Molecules (2020) Vol. 25, Iss. 5, pp. 1018-1018
Open Access | Times Cited: 15
Design and synthesis of conformationally constrained N,N-disubstituted 1,4-diazepanes as potent orexin receptor antagonists
Paul J. Coleman, John D. Schreier, Georgia B. McGaughey, et al.
Bioorganic & Medicinal Chemistry Letters (2010) Vol. 20, Iss. 7, pp. 2311-2315
Closed Access | Times Cited: 18
Cocaine abuse and midbrain circuits: Functional anatomy of hypocretin/orexin transmission and therapeutic prospect
Steven J. Simmons, Taylor A. Gentile
Brain Research (2019) Vol. 1731, pp. 146164-146164
Open Access | Times Cited: 14
The Discovery of Suvorexant: Lessons Learned That Can Be Applied to Other CNS Drug Development Efforts
Jason M. Uslaner, W. Joseph Herring, Paul J. Coleman
ACS Pharmacology & Translational Science (2020) Vol. 3, Iss. 1, pp. 161-168
Open Access | Times Cited: 13
Orexin Receptor Antagonists in Development for Insomnia and CNS Disorders
Scott D. Kuduk, Christopher J. Winrow, Paul J. Coleman
Annual reports in medicinal chemistry (2013), pp. 73-87
Closed Access | Times Cited: 11
Pharmacological Validation of Candidate Causal Sleep Genes Identified in an N2 Cross
Joseph I. Brunner, Anthony L. Gotter, Joshua Millstein, et al.
Journal of Neurogenetics (2011) Vol. 25, Iss. 4, pp. 167-181
Open Access | Times Cited: 11
Discovery of dual orexin receptor antagonists with rat sleep efficacy enabled by expansion of the acetonitrile-assisted/diphosgene-mediated 2,4-dichloropyrimidine synthesis
Anthony J. Roecker, Swati P. Mercer, C. Meacham Harrell, et al.
Bioorganic & Medicinal Chemistry Letters (2014) Vol. 24, Iss. 9, pp. 2079-2085
Closed Access | Times Cited: 10
Laboratory and practical synthesis of Suvorexant, a selective dual orexin receptor antagonist
Daisuke Minehira, Satoyuki Takahara, Isao Adachi, et al.
Tetrahedron Letters (2014) Vol. 55, Iss. 42, pp. 5778-5780
Closed Access | Times Cited: 10
Seven-membered rings
Adam G. Meyer, Alex C. Bissember, Christopher J. T. Hyland, et al.
Progress in heterocyclic chemistry (2021), pp. 565-614
Closed Access | Times Cited: 9

Scroll to top